Fred Valentine

7.8k total citations · 2 hit papers
80 papers, 5.8k citations indexed

About

Fred Valentine is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Fred Valentine has authored 80 papers receiving a total of 5.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 46 papers in Virology and 27 papers in Immunology. Recurrent topics in Fred Valentine's work include HIV Research and Treatment (45 papers), HIV/AIDS Research and Interventions (29 papers) and HIV/AIDS drug development and treatment (29 papers). Fred Valentine is often cited by papers focused on HIV Research and Treatment (45 papers), HIV/AIDS Research and Interventions (29 papers) and HIV/AIDS drug development and treatment (29 papers). Fred Valentine collaborates with scholars based in United States, Kenya and Germany. Fred Valentine's co-authors include Douglas D. Richman, Joseph J. Eron, H. Sherwood Lawrence, Charles J. Gonzalez, Roy M. Gulick, John W. Mellors, Emilio A. Emini, Diane V. Havlir, Anne R. Meibohm and Leslie Jonas and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Fred Valentine

79 papers receiving 5.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy

1997 1.5k citations Roy M. Gulick, John W. Mellors et al. New England Journal of Medicine profile →
Zidovudine in Asymptomatic Human Immunodeficiency Virus Infection

1990 951 citations Paul A. Volberding, Richard C. Reichman et al. New England Journal of Medicine profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Fred Valentine	3.6k	3.5k	1.5k	1.2k	571	80	5.8k
James O. Kahn	3.6k 1.0×	3.5k 1.0×	1.7k 1.1×	1.3k 1.2×	484 0.8×	70	5.8k
Richard C. Reichman	4.1k 1.1×	3.3k 1.0×	3.2k 2.1×	889 0.8×	679 1.2×	116	7.4k
C. Rouzioux	2.7k 0.8×	3.8k 1.1×	1.8k 1.2×	2.3k 2.0×	727 1.3×	51	6.1k
Jan van Lunzen	3.1k 0.9×	3.7k 1.1×	1.3k 0.8×	2.0k 1.7×	574 1.0×	145	6.2k
Michael H. Grieco	3.8k 1.0×	2.3k 0.7×	2.6k 1.7×	902 0.8×	589 1.0×	87	6.7k
Harold A. Kessler	2.6k 0.7×	2.8k 0.8×	2.0k 1.3×	1.1k 1.0×	278 0.5×	126	5.2k
Jeffrey M. Jacobson	2.1k 0.6×	2.5k 0.7×	1.4k 0.9×	1.3k 1.1×	828 1.5×	133	5.0k
Keith Henry	4.4k 1.2×	3.9k 1.1×	1.9k 1.2×	824 0.7×	563 1.0×	135	7.2k
Cécile Tremblay	2.7k 0.8×	3.2k 0.9×	1.7k 1.1×	1.9k 1.6×	854 1.5×	240	6.1k
Jeffrey Chodakewitz	4.2k 1.2×	4.0k 1.2×	1.3k 0.9×	880 0.8×	658 1.2×	24	6.2k

Countries citing papers authored by Fred Valentine

Since Specialization

Citations

This map shows the geographic impact of Fred Valentine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Valentine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Valentine more than expected).

Fields of papers citing papers by Fred Valentine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Valentine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Valentine. The network helps show where Fred Valentine may publish in the future.

Co-authorship network of co-authors of Fred Valentine

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Valentine. A scholar is included among the top collaborators of Fred Valentine based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Valentine. Fred Valentine is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Silvera, Richard, et al.. (2010). The Development and Implementation of an Outreach Program to Identify Acute and Recent HIV Infections in New York City. The Open AIDS Journal. 4(1). 76–83. 9 indexed citations

Sivapalasingam, Sumathi, et al.. (2009). Monitoring Virologic Responses to Antiretroviral Therapy in HIV-Infected Adults in Kenya: Evaluation of a Low-Cost Viral Load Assay. PLoS ONE. 4(8). e6828–e6828. 20 indexed citations

Daskalakis, Demetre, Richard Silvera, Kyle T. Bernstein, et al.. (2009). Implementation of HIV Testing at 2 New York City Bathhouses: From Pilot to Clinical Service. Clinical Infectious Diseases. 48(11). 1609–1616. 62 indexed citations

Sivapalasingam, Sumathi, Jeffrey S. Kennedy, William Borkowsky, et al.. (2007). Immunological Memory after Exposure to Variola Virus, Monkeypox Virus, and Vaccinia Virus. The Journal of Infectious Diseases. 195(8). 1151–1159. 22 indexed citations

Vogler, Mary, Hedy Teppler, Rebecca Gelman, et al.. (2004). Daily Low-Dose Subcutaneous Interleukin-2 Added To Single- or Dual-Nucleoside Therapy in HIV Infection Does Not Protect Against CD4+ T-Cell Decline or Improve Other Indices of Immune Function: Results of a Randomized Controlled Clinical Trial (ACTG 248). JAIDS Journal of Acquired Immune Deficiency Syndromes. 36(1). 576–587. 15 indexed citations

Frank, Ian, Ronald J. Bosch, Susan A. Fiscus, et al.. (2004). Activity, Safety, and Immunological Effects of Hydroxyurea Added to Didanosine in Antiretroviral-Naive and Experienced HIV Type 1-Infected Subjects: A Randomized, Placebo-Controlled Trial, ACTG 307. AIDS Research and Human Retroviruses. 20(9). 916–926. 21 indexed citations

Kilby, J Michael, Jacob Lalezari, Joseph J. Eron, et al.. (2003). The Safety, Plasma Pharmacokinetics, and Antiviral Activity of Subcutaneous Enfuvirtide (T-20), a Peptide Inhibitor of gp41-Mediated Virus Fusion, in HIV-Infected Adults. AIDS Research and Human Retroviruses. 19(1). 83–83. 6 indexed citations

Lalezari, Jacob, Joseph J. Eron, Margrit Carlson, et al.. (2003). A phase II clinical study of the long-term safety and antiviral activity of enfuvirtide-based antiretroviral therapy. AIDS. 17(5). 691–698. 113 indexed citations

Kilby, J Michael, Jacob Lalezari, Joseph J. Eron, et al.. (2002). The Safety, Plasma Pharmacokinetics, and Antiviral Activity of Subcutaneous Enfuvirtide (T-20), a Peptide Inhibitor of gp41-Mediated Virus Fusion, in HIV-Infected Adults. AIDS Research and Human Retroviruses. 18(10). 685–693. 152 indexed citations

10.

Skurnick, Joan, Paul Palumbo, Anthony L. DeVico, et al.. (2002). Correlates of Nontransmission in US Women at High Risk of Human Immunodeficiency Virus Type 1 Infection through Sexual Exposure. The Journal of Infectious Diseases. 185(4). 428–438. 54 indexed citations

11.

Kundu, Smriti K., David Katzenstein, Fred Valentine, et al.. (1997). Effect of Therapeutic Immunization With Recombinant gp160 HIV-1 Vaccine on HIV-1 Proviral DNA and Plasma RNA. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology. 15(4). 269–274. 16 indexed citations

12.

Gulick, Roy M., John W. Mellors, Diane V. Havlir, et al.. (1997). Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy. New England Journal of Medicine. 337(11). 734–739. 1531 indexed citations breakdown →

13.

Lambert, John S., Mindell Seidlin, Fred Valentine, Richard C. Reichman, & Raphael Dolin. (1993). Didanosine: Long-Term Follow-Up of Patients in a Phase 1 Study. Clinical Infectious Diseases. 16(Supplement_1). S40–S45. 9 indexed citations

14.

Kelker, H C, Mindell Seidlin, Mary Vogler, & Fred Valentine. (1992). Lymphocytes from Some Long-Term Seronegative Heterosexual Partners of HIV-Infected Individuals Proliferate in Response to HIV Antigens. AIDS Research and Human Retroviruses. 8(8). 1355–1359. 42 indexed citations

15.

Pai, Sudhakar M., Umesh Shukla, Thaddeus H. Grasela, et al.. (1992). Population Pharmacokinetic Analysis of Didanosine (2′,3′‐Dideoxyinosine) Plasma Concentrations Obtained in Phase I Clinical Trials in Patients with AIDS or AIDS‐Related Complex. The Journal of Clinical Pharmacology. 32(3). 242–247. 21 indexed citations

16.

Valentine, Fred, Mindell Seidlin, Howard S. Höchster, & Maura Laverty. (1990). Phase I Study of 2′,3′-Dideoxyinosine: Experience with 19 Patients at New York University Medical Center. Clinical Infectious Diseases. 12(Supplement_5). S534–S539. 24 indexed citations

17.

Chachoua, Abraham, Michael D. Green, Fred Valentine, & Franco M. Muggia. (1989). Phase I/II Trial of Thymostimulin in Opportunistic Infections of the Acquired Immune Deficiency Syndrome. Cancer Investigation. 7(3). 225–229. 2 indexed citations

18.

Seidlin, Mindell, et al.. (1988). Prevalence of HIV infection in New York call girls.. PubMed. 1(2). 150–4. 16 indexed citations

19.

Cohen, Lisa J., Robert S. Holzman, Fred Valentine, & H. Sherwood Lawrence. (1976). Requirement of precommitted cells as targets for the augmentation of lymphocyte proliferation by leukocyte dialysates.. The Journal of Experimental Medicine. 143(4). 791–804. 26 indexed citations

20.

Marshall, William H., Fred Valentine, & H. Sherwood Lawrence. (1969). CELLULAR IMMUNITY IN VITRO. The Journal of Experimental Medicine. 130(2). 327–343. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact